DUSP26 protects against acute kidney injury by dephosphorylating p53 at serine 312

Ying Fu1,2,3, Yu Xiang1, Yun Han1

  • 1Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, Institute of Nephrology, The Second Xiangya Hospital at Central South University, Changsha, China.

Nature Communications
|February 26, 2026
PubMed

Insights

Dual-specificity phosphatase 26 (DUSP26) protects against acute kidney injury (AKI) by regulating p53. Reduced DUSP26 expression exacerbates kidney tubule damage, while its restoration offers protection, revealing a potential therapeutic target.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Acute kidney injury (AKI) is a major cause of patient mortality.
  • The molecular mechanisms underlying kidney tubule damage in AKI are not fully elucidated.
  • Identifying novel regulators of AKI is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of dual-specificity phosphatase 26 (DUSP26) in kidney tubule injury during AKI.
  • To elucidate the molecular mechanisms by which DUSP26 influences AKI.
  • To evaluate the therapeutic potential of targeting the DUSP26-p53 pathway in AKI.

Main Methods:

  • Analysis of DUSP26 expression in human kidney biopsies and murine AKI models.
  • Investigation of DUSP26 promoter methylation in kidney tubular cells.
  • Assessment of DUSP26 function using gene knockout and knock-in models.
  • Biochemical assays to determine DUSP26 interaction with p53.
  • Pharmacological manipulation of DUSP26 activity in AKI and liver ischemia-reperfusion injury models.

Main Results:

  • DUSP26 expression is significantly reduced in kidney biopsies from AKI patients and in murine AKI models.
  • Reduced DUSP26 expression in AKI is associated with hypermethylation of its gene promoter.
  • Loss of DUSP26 exacerbates kidney tubule injury, whereas DUSP26 expression confers protection.
  • DUSP26 directly dephosphorylates p53 at serine 312, reducing p53-mediated apoptosis.
  • Pharmacological inhibition of DUSP26 worsens AKI and liver injury, while DUSP26 overexpression is protective.

Conclusions:

  • DUSP26 is a critical regulator of kidney tubule injury in AKI.
  • The DUSP26-p53 signaling axis plays a key role in protecting against AKI.
  • DUSP26 dephosphorylates p53 to dampen pro-apoptotic signaling.
  • Targeting the DUSP26-p53 pathway represents a promising therapeutic strategy for AKI.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.4K